Literature DB >> 27251919

The importance of interactions between atrial fibrillation and heart failure.

Muhammad A Khan1, Duwarakan K Satchithananda2, Mamas A Mamas3.   

Abstract

Heart failure (HF) and atrial fibrillation (AF) are among the commonest cardiovascular conditions encountered in clinical practice and frequently coexist. Over the last decade, they have evolved into global cardiovascular epidemics. This, in turn, has huge clinical and economic implications. There is ample evidence that AF and HF have a mutually deleterious effect on each other. AF is not only a marker of HF severity but also affects HF prognosis independently. This article presents the close pathophysiological relationship between AF and HF and the adverse prognostic consequences of this bidirectional interaction. The scope of various therapeutic modalities and their potential impacts are discussed briefly.
© 2016 Royal College of Physicians.

Entities:  

Keywords:  Atrial fibrillation; heart failure; pathophysiology; prognosis; thromboprophylaxis

Mesh:

Year:  2016        PMID: 27251919      PMCID: PMC5922708          DOI: 10.7861/clinmedicine.16-3-272

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  25 in total

1.  A comparison of rate control and rhythm control in patients with atrial fibrillation.

Authors:  D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

2.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

3.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

Authors:  John J V McMurray; Stamatis Adamopoulos; Stefan D Anker; Angelo Auricchio; Michael Böhm; Kenneth Dickstein; Volkmar Falk; Gerasimos Filippatos; Cândida Fonseca; Miguel Angel Gomez-Sanchez; Tiny Jaarsma; Lars Køber; Gregory Y H Lip; Aldo Pietro Maggioni; Alexander Parkhomenko; Burkert M Pieske; Bogdan A Popescu; Per K Rønnevik; Frans H Rutten; Juerg Schwitter; Petar Seferovic; Janina Stepinska; Pedro T Trindade; Adriaan A Voors; Faiez Zannad; Andreas Zeiher; Jeroen J Bax; Helmut Baumgartner; Claudio Ceconi; Veronica Dean; Christi Deaton; Robert Fagard; Christian Funck-Brentano; David Hasdai; Arno Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Theresa McDonagh; Cyril Moulin; Bogdan A Popescu; Zeljko Reiner; Udo Sechtem; Per Anton Sirnes; Michal Tendera; Adam Torbicki; Alec Vahanian; Stephan Windecker; Theresa McDonagh; Udo Sechtem; Luis Almenar Bonet; Panayiotis Avraamides; Hisham A Ben Lamin; Michele Brignole; Antonio Coca; Peter Cowburn; Henry Dargie; Perry Elliott; Frank Arnold Flachskampf; Guido Francesco Guida; Suzanna Hardman; Bernard Iung; Bela Merkely; Christian Mueller; John N Nanas; Olav Wendelboe Nielsen; Stein Orn; John T Parissis; Piotr Ponikowski
Journal:  Eur J Heart Fail       Date:  2012-08       Impact factor: 15.534

4.  Atrial fibrillation in heart failure: The sword of Damocles revisited.

Authors:  Muhammad A Khan; Fozia Ahmed; Ludwig Neyses; Mamas A Mamas
Journal:  World J Cardiol       Date:  2013-07-26

5.  Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.

Authors:  Lars G Olsson; Karl Swedberg; Anique Ducharme; Christopher B Granger; Eric L Michelson; John J V McMurray; Margareta Puu; Salim Yusuf; Marc A Pfeffer
Journal:  J Am Coll Cardiol       Date:  2006-04-27       Impact factor: 24.094

6.  Rhythm control versus rate control for atrial fibrillation and heart failure.

Authors:  Denis Roy; Mario Talajic; Stanley Nattel; D George Wyse; Paul Dorian; Kerry L Lee; Martial G Bourassa; J Malcolm O Arnold; Alfred E Buxton; A John Camm; Stuart J Connolly; Marc Dubuc; Anique Ducharme; Peter G Guerra; Stefan H Hohnloser; Jean Lambert; Jean-Yves Le Heuzey; Gilles O'Hara; Ole Dyg Pedersen; Jean-Lucien Rouleau; Bramah N Singh; Lynne Warner Stevenson; William G Stevenson; Bernard Thibault; Albert L Waldo
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

7.  Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation (CASTLE-AF) - study design.

Authors:  Nassir F Marrouche; Johannes Brachmann
Journal:  Pacing Clin Electrophysiol       Date:  2009-08       Impact factor: 1.976

8.  Long-term follow-up after atrial fibrillation ablation in patients with impaired left ventricular systolic function: the importance of rhythm and rate control.

Authors:  Sotirios Nedios; Philipp Sommer; Nikolaos Dagres; Jedrzej Kosiuk; Arash Arya; Sergio Richter; Thomas Gaspar; Nikolaos Kanagkinis; Borislav Dinov; Christopher Piorkowski; Andreas Bollmann; Gerhard Hindricks; Sascha Rolf
Journal:  Heart Rhythm       Date:  2013-12-27       Impact factor: 6.343

9.  A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure.

Authors:  Mamas A Mamas; Jane C Caldwell; Sanoj Chacko; Clifford J Garratt; Farzin Fath-Ordoubadi; Ludwig Neyses
Journal:  Eur J Heart Fail       Date:  2009-07       Impact factor: 15.534

10.  Overview of the DIG trial.

Authors:  Joseph F Collins; Debra Egan; Salim Yusuf; Rekha Garg; William O Williford; Nancy Geller
Journal:  Control Clin Trials       Date:  2003-12
View more
  3 in total

1.  Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study.

Authors:  Christopher Papandreou; Mònica Bulló; Pablo Hernández-Alonso; Miguel Ruiz-Canela; Jun Li; Marta Guasch-Ferré; Estefanía Toledo; Clary Clish; Dolores Corella; Ramon Estruch; Emilio Ros; Montserrat Fitó; Angel Alonso-Gómez; Miquel Fiol; José M Santos-Lozano; Lluís Serra-Majem; Liming Liang; Miguel A Martínez-González; Frank B Hu; Jordi Salas-Salvadó
Journal:  Clin Chem       Date:  2021-01-08       Impact factor: 8.327

2.  Does rhythm matter in acute heart failure? An insight from the British Society for Heart Failure National Audit.

Authors:  Simon G Anderson; Ahmad Shoaib; Phyo Kyaw Myint; John G Cleland; Suzanna M Hardman; Theresa A McDonagh; Henry Dargie; Bernard Keavney; Clifford J Garratt; Mamas A Mamas
Journal:  Clin Res Cardiol       Date:  2019-04-08       Impact factor: 5.460

3.  Rate of Heart Failure Following Atrial Fibrillation According to Presence of Family History of Dilated Cardiomyopathy or Heart Failure: A Nationwide Study.

Authors:  Magnus N Ebbesen; Maria D'Souza; Charlotte Andersson; Jawad H Butt; Christian Madelaire; Tor Biering-Sorensen; Morten Lock-Hansen; Soren Lund Kristensen; Gunnar Gislason; Lars Kober; Christian Torp-Pedersen; Morten Schou
Journal:  J Am Heart Assoc       Date:  2021-10-30       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.